Literature DB >> 2907008

[3H]zacopride: ligand for the identification of 5-HT3 recognition sites.

N M Barnes1, B Costall, R J Naylor.   

Abstract

[3H]Zacopride displayed saturable binding to homogenates of the rat entorhinal cortex as measured by the inclusion of the 5-HT3 receptor antagonist BRL43694 in the incubation media. Scatchard analysis indicated a single high affinity binding site (KD 0.76 +/- 0.08 nM, Bmax 77.5 +/- 6.5 fmol (mg protein)-1) with a Hill slope close to unity. Other 5-HT3 receptor antagonists (zacopride, ICS 205-930, GR38032F, GR65630, metoclopramide and cocaine) also competed for the binding site displacing 60% of the total [3H]zacopride binding. 5-HT and 2-methyl-5-HT also were competitive antagonists for [3H]zacopride binding whereas 5-HT1/5-HT2 agonists and antagonists, and agents acting on other neurotransmitter receptors had Ki values greater than 10(-5) M. It is concluded that [3H]zacopride may prove a useful ligand for the study of 5-HT3 recognition sites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907008     DOI: 10.1111/j.2042-7158.1988.tb05300.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  20 in total

1.  Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract.

Authors:  S Champaneria; B Costall; R J Naylor; D W Robertson
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

Review 2.  The serotonin 5-HT1D receptor: a progress review.

Authors:  C Waeber; P Schoeffter; D Hoyer; J M Palacios
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

3.  The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.

Authors:  A Butler; C J Elswood; J Burridge; S J Ireland; K T Bunce; G J Kilpatrick; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem.

Authors:  J M Barnes; N M Barnes; B Costall; I L Naylor; R J Naylor; J A Rudd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

5.  Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J J Turner; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

6.  [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.

Authors:  D Hoyer; C Waeber; A Karpf; H Neijt; J M Palacios
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

7.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

8.  Serotonergic modulation of Neural activities in the entorhinal cortex.

Authors:  Saobo Lei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

9.  Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?

Authors:  N Andrews; S E File
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Synthesis and evaluation of (S)-[(18)F]fesetron in the rat brain as a potential PET imaging agent for serotonin 5-HT3 receptors.

Authors:  Neema K Pithia; Christopher Liang; Xiang-Zuo Pan; Min-Liang Pan; Jogeshwar Mukherjee
Journal:  Bioorg Med Chem Lett       Date:  2016-03-08       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.